Islam Mohamed, PharmBS, MS, PhD

Islam Mohamed, PharmBS, MS, PhD

Department of Pharmaceutical and Biomedical Sciences
Assistant Professor - Pharmacology

Phone: (916) 686-8537
Fax: (916) 686-8142


Dr. Islam Mohamed is an Assistant Professor at the Department of Pharmaceutical & Biomedical Sciences at California Northstate University College of Pharmacy (CNUCOP). Dr. Mohamed earned his Bachelor of Pharmacy Degree from Ain-Sham University in Egypt in 2005, followed by his MS degree in Neuroscience as a Fulbright scholar from SUNY at Buffalo NY in 2008, and his PhD from the College of Pharmacy at the University of Georgia in the Clinical and Experimental Therapeutics program in 2014. After which, he completed his postdoctoral training at the Division of Cardiology at Emory University School of Medicine, where in parallel, he also finished his additional training as an In-Patient Pharmacist Intern at Emory University Hospital Midtown before joining CNUCOP in 2017. Dr. Mohamed’s track-record includes several publications, outstanding awards, invitations for oral presentations, research funding support and hands-on experience in PharmD curriculum and assessments design and ACPE accreditation. Dr. Mohamed has 12 high impact original research publications and more than 28 peer-reviewed abstract presentations to date in highly recognized research conferences. In addition to garnering the prestigious American Heart Association Fellowship award twice, at both the Pre- and Post-doctoral levels. In 2018, Dr. Mohamed was awarded the Early Career Investigator International Travel Award, from the International Society for Eye Research (ISER), Belfast, Northern Ireland. Most recently, Dr. Mohamed was also awarded the 2021 Division of Pharmacology Educators Travel Award presented by the American Society for American Society of Pharmacology & Experimental Therapeutics (ASPET), followed by the 2021 American Association of Colleges of Pharmacy (AACP) Biological Sciences section Excellence in Teaching Award. Moreover, Dr. Mohamed also serves as a Research Mentor for the prestigious American Foundation of Pharmaceutical Education (AFPE) Gateway Award for one of CNUCOP outstanding Class of 2022 PharmD candidates (Ms. Vy Tran Luu) for their ongoing research on micro-RNA regulation of shear-stress-induced vascular inflammation.

Research Interest

  • Shear stress modulation of vascular inflammation
  • Vascular micro-RNAs and development of atherosclerosis
  • Interaction between metabolic and vascular diseases
  • Micro- and macrovascular complications of obesity, diabetes and insulin resistance
  • Curriculum design and assessment
  • Scholarship of Teaching, Learning in Pharmacy & Pharmacology Education


  • Complete list of publications and citation indices in the Google Scholar home page
    • Original Research Articles
      • Mohamed IN, Sheibani N, El-Remessy AB. Deletion of Thioredoxin-Interacting Protein (TXNIP) Abrogates High Fat Diet-induced Retinal Leukostasis, Barrier Dysfunction and Microvascular Degeneration in a Mouse Obesity Model: Int J Mol Sci, 2020.
      • Mohamed IN*, Sarhan NR*, Eladl MA, El-Remessy AB and El-Sherbiny M. Deletion of Thioredoxin-interacting protein ameliorates high fat diet-induced non-alcoholic steatohepatitis through modulation of Toll-like receptor 2-NLRP3-inflammasome axis: Histological and immunohistochemical study. Acta Histochemica, 2018 (*Equal contribution).
      • Elshaer SL*, Mohamed IN*, Coucha M*, Altantawi S, Eldahshan W, Bartasis ML, Shanab AY, Lorys R, El-Remessy AB. Deletion of TXNIP mitigates high fat diet-impaired angiogenesis and prevents inflammation in a mouse model of critical limb ischemia. Antioxidants. 2017 (*Equal contribution).
      • Coucha M*, Mohamed IN*, Elshaer SL, Mbata O, Bartasis ML, El-Remessy AB. High fat diet dysregulates microRNA-17-5p and triggers retinal inflammation: Role of ER-stress. World J Diabetes. 2017 Feb 15;8(2):56-65 (*Equal contribution).
      • Mysona BA, Matragoon S, Stephens M,2 Mohamed IN, Farooq A, Bartasis ML, Fouda AY, Shanab AY, Espinosa-Heidmann DG, El-Remessy AB. Imbalance of the nerve growth factor and its precursor as a potential biomarker for diabetic retinopathy. BioMed Research International, 2015.
      • Ishrat T, Mohamed IN, Pillai B, Soliman S, Fouda AY, Ergul A, El-Remessy AB, Fagan SC. Thioredoxin interacting protein: A novel target for neuroprotection in experimental thromboembolic stroke in mice. Mol Neurobiol. 2014.
      • El-Azab MF, Baldowski BR, Mysona BA, Shanab AY, Mohamed IN, Abdelsaid MA, Matragoon S, Bollinger KE, Saul A, El-Remessy AB. Deletion of TXNIP Preserve Retinal Neuronal Function by Mitigating Inflammation And Vascular Injury. Br J Pharmacol. 2014 Mar; 171(5):1299-313.
      • Mohamed IN, Hafez SS, Fairaq A, Ergul A, Imig JD, El-Remessy AB. Thioredoxin interacting protein is required for endothelial NLRP3-inflammasome activation and cell death in a rat model of high fat diet. Diabetologia. 2014 Feb;57(2):413-23.
      • Mohamed IN, Soliman SA, Alhusban AA, Matragoon S, Pillai BA, Elmarakby AA, El-Remessy AB. Diabetes exacerbates retinal oxidative stress, inflammation and microvascular degeneration in spontaneously hypertensive rats. J Molecular Vision. 2012 Jun;18:1457-66.
      • Dandona P, Mohamed I, Ghanim H, Sia CL, Dhindsa S, Dandona S, Makdissi A, Chaudhuri A. Insulin suppresses the expression of amyloid precursor protein, presenilins, and glycogen synthase kinase-3beta in peripheral blood mononuclear cells. J Clin Endocrinol Metab. 2011 Jun; 96(6):1783-8.
    • Review Articles & blogs
      • Elsobky Y, Mohamed IN. Medication trade names; are they intended to “Trick” or can they help to “Treat”? British Medical Journal, Evidence-Based Medicine Live Blog (BMJ-EBM Live Blog); July; 2019.
      • Mohamed IN, Ishrat T, Fagan SC, El-Remessy AB. Role of Inflammasome Activation in the Pathophysiology of Vascular Diseases of the Neurovascular Unit. Anti-oxidant and Redox signaling (forum review article), 2015.

Accomplishments and Awards

  • 2021: Research Mentor; American Foundation of Pharmaceutical Education (AFPE) Gateway Award for Class of 2022 Pharmacy Student.
  • 2021: Excellence in Teaching Award, American Association of Colleges of Pharmacy (AACP) Biological Sciences section, USA.
  • 2021: Pharmacology Educator Travel Award, The Division for Pharmacology Education, American Society of Pharmacology & Experimental Therapeutics (ASPET), USA.
  • 2018: Early Career Investigator Full International Travel Award, International Society for Eye Research (ISER), Belfast, Northern Ireland.
  • 2017: American Heart Association (AHA) Post-doctoral fellowship, USA.
  • 2016: Young Investigator Travel Award, Council on Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB), American Heart Association (AHA), USA.
  • 2016: Selected oral presentation, American Heart Association (AHA) Scientific Sessions, USA.
  • 2013: University of Georgia graduate school Travel Award, Association for Research in Vision and Ophthalmology (ARVO) meeting, USA.
  • 2012: American Heart Association (AHA) Pre-doctoral fellowship, USA.
  • 2012: University of Georgia graduate school Travel Award, Association for Research in Vision and Ophthalmology (ARVO) meeting, USA.
  • 2008: Fulbright MS full Scholarship, The US-Egypt Binational Fulbright Commission in Egypt.

By partnering with PioneerRx Pharmacy Software, our program allows students to learn in a real-world environment using the most installed software for independent pharmacies. Students enhance their clinical and functional skills by training in a pharmacy system that is innovative, robust, and feature-rich.